M. K. Hourfar

1.3k total citations
26 papers, 827 citations indexed

About

M. K. Hourfar is a scholar working on Infectious Diseases, Epidemiology and Biochemistry. According to data from OpenAlex, M. K. Hourfar has authored 26 papers receiving a total of 827 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Epidemiology and 8 papers in Biochemistry. Recurrent topics in M. K. Hourfar's work include Blood transfusion and management (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (6 papers). M. K. Hourfar is often cited by papers focused on Blood transfusion and management (8 papers), Hepatitis B Virus Studies (7 papers) and Hepatitis C virus research (6 papers). M. K. Hourfar collaborates with scholars based in Germany, Austria and United States. M. K. Hourfar's co-authors include Michael Schmidt, Erhard Seifried, W. Kurt Roth, Walid Sireis, C. Micha Nübling, Knut Gubbe, U. Mayr‐Wohlfart, Heinrich Scheiblauer, V. Brixner and Thomas Montag and has published in prestigious journals such as Hepatology, Journal of Clinical Microbiology and Clinical Chemistry.

In The Last Decade

M. K. Hourfar

26 papers receiving 781 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. K. Hourfar Germany 18 333 329 237 156 150 26 827
Walid Sireis Germany 14 236 0.7× 150 0.5× 167 0.7× 179 1.1× 162 1.1× 21 585
Francis Sarkodie United Kingdom 16 597 1.8× 204 0.6× 531 2.2× 112 0.7× 283 1.9× 23 979
Marco Koppelman Netherlands 21 372 1.1× 606 1.8× 392 1.7× 22 0.1× 37 0.2× 38 1.1k
Jean‐Pierre Allain United Kingdom 14 456 1.4× 541 1.6× 260 1.1× 52 0.3× 77 0.5× 16 1.1k
Michael Chudy Germany 19 711 2.1× 362 1.1× 668 2.8× 30 0.2× 110 0.7× 36 1.0k
Vito Scalia Canada 16 337 1.0× 161 0.5× 265 1.1× 95 0.6× 252 1.7× 34 745
M.P. Busch United States 17 542 1.6× 371 1.1× 290 1.2× 94 0.6× 265 1.8× 19 1.0k
Hannelore Willkommen Germany 11 103 0.3× 296 0.9× 29 0.1× 19 0.1× 32 0.2× 33 529
Peter L. Page United States 9 177 0.5× 371 1.1× 43 0.2× 91 0.6× 111 0.7× 13 748
Jaye P. Brodsky United States 10 170 0.5× 186 0.6× 131 0.6× 24 0.2× 70 0.5× 16 407

Countries citing papers authored by M. K. Hourfar

Since Specialization
Citations

This map shows the geographic impact of M. K. Hourfar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. K. Hourfar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. K. Hourfar more than expected).

Fields of papers citing papers by M. K. Hourfar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. K. Hourfar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. K. Hourfar. The network helps show where M. K. Hourfar may publish in the future.

Co-authorship network of co-authors of M. K. Hourfar

This figure shows the co-authorship network connecting the top 25 collaborators of M. K. Hourfar. A scholar is included among the top collaborators of M. K. Hourfar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. K. Hourfar. M. K. Hourfar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Michael, M. K. Hourfar, Walid Sireis, et al.. (2015). Evaluation of the effectiveness of a pathogen inactivation technology against clinically relevant transfusion‐transmitted bacterial strains. Transfusion. 55(9). 2104–2112. 43 indexed citations
2.
Jungbauer, Christof, M. K. Hourfar, Karin Stiasny, et al.. (2015). West Nile virus lineage 2 infection in a blood donor from Vienna, Austria, August 2014. Journal of Clinical Virology. 64. 16–19. 12 indexed citations
3.
Mueller, Markus M., M. K. Hourfar, E. Huber, et al.. (2012). Oxygen measurements in platelet fluids – a new non‐invasive method to detect bacterial contaminations in platelets. Transfusion Medicine. 22(3). 211–216. 5 indexed citations
4.
5.
Sireis, Walid, Brigitte Rüster, M. K. Hourfar, et al.. (2011). Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sanguinis. 101(3). 191–199. 30 indexed citations
6.
Hourfar, M. K., U. Mayr‐Wohlfart, Walid Sireis, et al.. (2010). Recipients potentially infected with parvovirus B19 by red blood cell products. Transfusion. 51(1). 129–136. 32 indexed citations
7.
Schmidt, Michael, Lutz Pichl, Christine Jork, et al.. (2009). Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes. Vox Sanguinis. 98(1). 37–46. 17 indexed citations
8.
Schmidt, Michael, et al.. (2009). BLOOD COMPONENTS: A new one‐platform flow cytometric method for residual cell counting in platelet concentrates. Transfusion. 49(12). 2604–2611. 5 indexed citations
9.
Schmidt, Michael, Klaus Korn, C. Micha Nübling, et al.. (2009). First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany. Transfusion. 49(9). 1836–1844. 53 indexed citations
10.
Hourfar, M. K., Karin Janetzko, Knut Gubbe, et al.. (2008). Sensitivity and specificity of Anti‐HBc screening assays – which assay is best for blood donor screening?. International Journal of Laboratory Hematology. 31(6). 649–656. 31 indexed citations
11.
12.
Schmidt, Michael, Camilla Drexler, Michaela Bayer, et al.. (2007). Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion. 47(10). 1775–1782. 50 indexed citations
13.
Schmidt, Michael, C. Micha Nübling, Heinrich Scheiblauer, et al.. (2006). Anti‐HBc screening of blood donors: a comparison of nine anti‐HBc tests. Vox Sanguinis. 91(3). 237–243. 57 indexed citations
14.
Schmidt, Michael, et al.. (2006). FACS technology used in a new rapid bacterial detection method. Transfusion Medicine. 16(5). 355–361. 23 indexed citations
15.
Schmidt, Michael, et al.. (2006). Fluorescence quencher improves scansystem™ for rapid bacterial detection. Vox Sanguinis. 90(4). 276–278. 3 indexed citations
16.
Schmidt, Michael, M. K. Hourfar, Julia E. Heck, et al.. (2006). A comparison of three rapid bacterial detection methods under simulated real‐life conditions. Transfusion. 46(8). 1367–1373. 25 indexed citations
17.
Schmidt, Michael, Julia E. Heck, Thomas Montag, et al.. (2005). Optimized Scansystem™ platelet kit for bacterial detection with enhanced sensitivity: detection within 24 h after spiking. Vox Sanguinis. 89(3). 135–139. 27 indexed citations
18.
Schmidt, Michael, W. Kurt Roth, Helmut E. Meyer, Erhard Seifried, & M. K. Hourfar. (2005). Nucleic acid test screening of blood donors for orthopoxviruses can potentially prevent dispersion of viral agents in case of bioterrorism. Transfusion. 45(3). 399–403. 12 indexed citations
19.
Hourfar, M. K., Michael Schmidt, Erhard Seifried, & W. Kurt Roth. (2005). Evaluation of an automated high‐volume extraction method for viral nucleic acids in comparison to a manual procedure with preceding enrichment. Vox Sanguinis. 89(2). 71–76. 26 indexed citations
20.
Schmidt, Michael, V. Brixner, Brigitte Rüster, et al.. (2004). NAT screening of blood donors for severe acute respiratory syndrome coronavirus can potentially prevent transfusion associated transmissions. Transfusion. 44(4). 470–475. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walid Sireis Breakdown of academic impact, for papers by Francis Sarkodie Breakdown of academic impact, for papers by Marco Koppelman Breakdown of academic impact, for papers by Jean‐Pierre Allain Breakdown of academic impact, for papers by Michael Chudy Breakdown of academic impact, for papers by Vito Scalia Breakdown of academic impact, for papers by M.P. Busch Breakdown of academic impact, for papers by Hannelore Willkommen Breakdown of academic impact, for papers by Peter L. Page Breakdown of academic impact, for papers by Jaye P. Brodsky
Rankless by CCL
2026